Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2020 Oct 2;21(2):273. doi: 10.1038/s41397-020-00193-6

Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

Maja Guberina 1,, Ali Sak 1, Christoph Pöttgen 1, Ingeborg Tinhofer-Keilholz 2,3, Volker Budach 2,3, Panagiotis Balermpas 4,5, Jens Von der Grün 4,5, Claus Michael Rödel 4,5, Eleni Gkika 6, Anca-Ligia Grosu 6,7, Amir Abdollahi 8,9,10,11,12, Jürgen Debus 8,9,10,12,13, Claus Belka 14,15,16, Steffi Pigorsch 14,17, Stephanie E Combs 14,17,18, David Mönnich 19,20, Daniel Zips 19,20, Chiara De-Colle 20, Stefan Welz 20, Annett Linge 21,22,23,24,25, Fabian Lohaus 21,22,23,24,25, Gustavo Baretton 23,24,25,26,27, Thomas Gauler 1, Michael Baumann 21,22,25,27, Mechthild Krause 11,21,22,23,24,25,27, Martin Schuler 28,29,30, Agnes Bankfalvi 31, Benedikt Höing 32, Stephan Lang 32, Martin Stuschke 1,28
PMCID: PMC7997801  PMID: 33009516

Correction to: The Pharmacogenomics Journal

10.1038/s41397-020-0174-1

The original version of this Article contained an error in the spelling of the author Eleni Gkika, which was incorrectly given as Eleni Gikka. As well as the author Stephanie E. Combs, this was incorrectly given as Stephanie Combs. Both have now been corrected in the PDF and HTML versions of the Article.

Footnotes

The original article can be found online at 10.1038/s41397-020-0174-1.


Articles from The Pharmacogenomics Journal are provided here courtesy of Nature Publishing Group

RESOURCES